Infliximab Concept

subject area of

• 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis  Academic Article
• A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease  Academic Article
• Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis  Academic Article
• Anti-TNFα therapy in immune-mediated subfertility: State of the art  Academic Article
• Anti-cytokine targeted therapies for ANCA-associated vasculitis  Academic Article
• Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis  Academic Article
• Biologic survival.  Academic Article
• Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease  Academic Article
• Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Academic Article
• Changes in the gut microbiome associated with infliximab in patients with bipolar disorder  Academic Article
• Clinical Decision Support Tool for Infliximab in Crohn’s Disease  Academic Article
• Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?  Academic Article
• Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease  Conference Paper
• Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease  Academic Article
• Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis  Academic Article
• Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis  Academic Article
• Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs  Academic Article
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Academic Article
• Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?  Academic Article
• Editorial: methotrexate in patients with Crohn's disease refractory to anti-TNF therapy-moving backwards yet forward?  Academic Article
• Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis  Academic Article
• Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis  Academic Article
• End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease  Academic Article
• Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab  Academic Article
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey  Academic Article
• Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients  Academic Article
• Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis  Academic Article
• Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients  Academic Article
• Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors  Academic Article
• Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection  Academic Article
• Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.  Academic Article
• Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis  Academic Article
• Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms  Academic Article
• Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors’ reply  Academic Article
• Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis  Academic Article
• Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease  Academic Article
• Nail Psoriasis and Biologics  Academic Article
• Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab  Academic Article
• Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis  Academic Article
• Patient outcomes after anti TNF-α drugs for Crohn’s disease  Academic Article
• Peripheral inflammatory biomarkers define biotypes of bipolar depression  Academic Article
• Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics  Academic Article
• Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database  Academic Article
• Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis  Academic Article
• Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab  Academic Article
• Resource utilization during pediatric to adult transfer of care in IBD  Academic Article
• Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis  Academic Article
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease  Academic Article
• Review article: dose optimisation of infliximab for acute severe ulcerative colitis  Academic Article
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids  Academic Article
• The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma  Academic Article
• The Safety of Infliximab Infusions in the Community Setting  Academic Article
• The efficacy and safety of either infliximab or adalimumab in 362 patients with anti-TNF-α naïve Crohn's disease  Academic Article
• The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario  Academic Article
• Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements  Academic Article
• Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease  Academic Article